US 7211252
Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
granted A61KA61K38/00A61P
Quick answer
US patent 7211252 (Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists) held by The Board of Regents of the University of Texas System expires Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue May 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61P, A61P19/00, A61P19/08